Genomic Health
Genomic Health, Inc. was a Redwood City, California molecular diagnostics company founded in 2000 and known for its Oncotype DX suite of genomic tests, which analyze tumor gene-expression to guide treatment decisions in breast, colon, and prostate cancer. Backed by Kleiner Perkins, it went public in 2005 and was acquired by Exact Sciences in November 2019. It no longer operates as an independent company: the genomichealth.com domain now 301-redirects to exactsciences.com, and there is no independent Genomic Health developer portal, public API, or documentation surface. This record is retained as a VC-portfolio lead; no live API artifacts could be enriched.
Genomic Health is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Genomics, Diagnostics, and Oncology.